Hydralazine-Associated Pulmonary-Renal Syndrome
- PMID: 33538489
- DOI: 10.1097/MJT.0000000000001313
Hydralazine-Associated Pulmonary-Renal Syndrome
Conflict of interest statement
The authors have no conflicts of interest to declare.
References
-
- Mansilla-Tinoco R, Harland SJ, Ryan PJ, et al. Hydralazine, antinuclear antibodies, and the lupus syndrome. BMJ. 1982;284:936–939.
-
- Ntatsaki E, Watts RA, Scott DG. Epidemiology of ANCA-associated vasculitis. Rheum Dis Clin North Am. 2010;36:447–461.
-
- McKinnon RA, Nebert DW. Possible role of cytochromes P450 in lupus erythematosus and related disorders. Lupus. 1994;3:473–478.
-
- Nishino T, Minami K, Uramatsu T, et al. An elderly patient with diabetic nephropathy complicated by ANCA-associated nephritis. Intern Med. 2012;51:1227–1232.
-
- Deng C, Lu Q, Zhang Z, et al. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum. 2003;48:746–756.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical